Pancreatic Cancer Vaccine Keeps 7 Patients Alive After 6 Years

A personalized mRNA vaccine helped eight pancreatic cancer patients generate powerful immune responses, and seven of them are still alive six years later.

The breakthrough offers new hope for one of the deadliest cancers, where fewer than 13% of patients survive five years.